| Symbol | CAMP |
|---|---|
| Name | CAMP4 THERAPEUTICS CORP |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | ONE KENDALL SQUARE, CAMBRIDGE, MA 02139 |
| Telephone | 617-651-8867 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001736730 |
| Description | None |
(10% Negative) CAMP4 THERAPEUTICS CORP (CAMP) Announces Delay in studies Trials for SYNGAP1-related disorder Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations
Read moreCAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder
Read moreCAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Read moreCAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read moreDirector WILLIAMS DOUGLAS E 🟢 acquired 28.0K shares (1 derivative) of Camp4 Therapeutics Corp (CAMP) at $4.34 Transaction Date: Jun 10, 2026 | Filing ID: 042863
Read moreDirector Young Richard A 🟢 acquired 28.0K shares (1 derivative) of Camp4 Therapeutics Corp (CAMP) at $4.34 Transaction Date: Jun 10, 2026 | Filing ID: 042862
Read moreDirector Holtzman Steven H 🟢 acquired 28.0K shares (1 derivative) of Camp4 Therapeutics Corp (CAMP) at $4.34 Transaction Date: Jun 10, 2026 | Filing ID: 042860
Read moreDirector Stewart Murray 🟢 acquired 28.0K shares (1 derivative) of Camp4 Therapeutics Corp (CAMP) at $4.34 Transaction Date: Jun 10, 2026 | Filing ID: 042859
Read moreDirector Nashat Amir 🟢 acquired 28.0K shares (1 derivative) of Camp4 Therapeutics Corp (CAMP) at $4.34 Transaction Date: Jun 10, 2026 | Filing ID: 042858
Read more